Nabla Bio
We use AI to design antibodies for intractable diseases
Company facts
- Founded
- 2021
- Employees
- 8
- Headquarters
- United States
About
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
Open positions

AI Platform Engineer
The Role We’re hiring a senior engineer to build core infrastructure and tools that connect our AI models to real-world use. You’ll work across the full stack — front-end, back-end, and ML infrastructure — to build…

Applied AI/Bio Scientist
The Role We’re hiring an exceptionally driven Applied AI/Bio Scientist to help push the boundaries of what’s possible in therapeutic design. You'll work across the full discovery stack — using state-of-the-art AI to…